APA (7th ed.) Citation

Stephan, C., Spinner, C. D., Rieke, A., Christensen, S., Mauss, S., Schreiber, S., . . . Stellbrink, H. (2025). Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final 24‐month results from the prospective German TAFNES cohort study. HIV Medicine, 26(2), 239. https://doi.org/10.1111/hiv.13728

Chicago Style (17th ed.) Citation

Stephan, Christoph, et al. "Effectiveness, Safety, and Patient‐reported Outcomes of Emtricitabine/tenofovir Alafenamide‐based Regimens for the Treatment of HIV‐1 Infection: Final 24‐month Results from the Prospective German TAFNES Cohort Study." HIV Medicine 26, no. 2 (2025): 239. https://doi.org/10.1111/hiv.13728.

MLA (9th ed.) Citation

Stephan, Christoph, et al. "Effectiveness, Safety, and Patient‐reported Outcomes of Emtricitabine/tenofovir Alafenamide‐based Regimens for the Treatment of HIV‐1 Infection: Final 24‐month Results from the Prospective German TAFNES Cohort Study." HIV Medicine, vol. 26, no. 2, 2025, p. 239, https://doi.org/10.1111/hiv.13728.